Evidence map›Paper›PMID 35510079›Full record

ArticleProstate international2022

Diagnostic value of integrated

Yuping Zeng, Xiaoming Leng, Hengbin Liao, Guihua Jiang, Ping Chen

Abstract read
In one paragraph

Article in Prostate international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Efficacy of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. The Role of [Cancers · 2022
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuping ZengThe Second School of Clinical Medicine, Southern Medical University, Guangzhou 510317, China.
Xiaoming LengGuangzhou Universal Medical Imaging Diagnostic Center, Guangzhou 510080, China.
Hengbin LiaoGuangzhou Universal Medical Imaging Diagnostic Center, Guangzhou 510080, China.
Guihua JiangDepartment of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou 510317, China.
Ping ChenGuangzhou Universal Medical Imaging Diagnostic Center, Guangzhou 510080, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the diagnostic value of fluorine 18 ( Materials and methods: The study enrolled 29 patients with suspected PCa preoperatively who underwent Results: Of the 48 suspected PCa lesions in 29 patients, 38 were pathologically diagnosed with clinically significant PCa and 10 with nonprostate cancer (non-PCa) lesions. Compared with the pathological results, Conclusion: The diagnostic value of

Indexed as

18F-PSMA-100718F-PSMA-1007, Fluorine 18-labeled prostate-specific membrane antigen-1007ADC, Apparent diffusion coefficientAUC, Area under the curvebpMRIbpMRI, Biparametric MRICI, Confidence intervalDCE, Dynamic contrast-enhancedDiagnostic valueDWI, Diffusion-weighted imagingISUP, International Society of Urological PathologympMRI, Multiparametric magnetic resonance imagingNPV, Negative predictive valuePCa, Prostate cancerPET/MRIPET/MRI, Positron emission tomography/Magnetic resonance imagingPI-RADS, Prostate imaging reporting and data systemPPV, Positive predictive valueProstate cancerPSA, Prostate-specific antigenROC, Receiver-operating characteristicROI, Region of interestSUVmax, Optimal standardized uptake valueT1WI, T1-weighted imagingT2WI, T2-weighted imagingTRUS, Transrectal ultrasonography

Identifiers

PMID35510079
PMCPMC9052074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.